NCT06617754View on ClinicalTrials.gov

International Severe CRSwNP Registry 2024-2028

Active, not recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2032

Conditions
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
BIOLOGICAL

Biologic drugs

Biologic drugs including Mepolizumab, Dupilumab, Omalizumab, Tezepelumab, or future monoclonal antibodies

Trial Locations (1)

DK-2100

Department of Rhinolaryngology Head & Neck surgery and Audiology, Copenhagen

All Listed Sponsors
collaborator

The European Forum for Research and Education in Allergy and Airway Diseases

OTHER

lead

Vibeke Backer

OTHER